Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)

Stopped early · Phase 3 · Has a placebo group

Conditions studied: BK Virus Infection, Hemorrhagic Cystitis

In brief

Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC).

Key facts

Study ID
NCT04390113
Run by
AlloVir
People needed
97
Starts
2021-03-18
Expected to finish
2024-01-30
Last updated by the study team
2024-05-14

Who can join

Age: 1 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.